Tag: innovation

TORONTO, July 3, 2025 /CNW/ - The 3rd Transatlantic Symposium on Sustainable Development in Higher Education, hosted by International Business University (IBU) in Toronto,...

The Texas Legislature positions Texas as a national and global leader in next-generation nuclear technology, water security and medical research  ABILENE, Texas, July 3, 2025...

LUXEMBOURG, July 3, 2025 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company"), a leading sustainable production company in South America and Tether...

Bitget Wallet, the leading non-custodial crypto wallet, celebrated their new crypto-linked card, launched in partnership with Mastercard and infra..

LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as a Major Player...

LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as a Major Player...

TAMPA, Fla., July 3, 2025 /PRNewswire/ -- Verdantas, a leader in digitally enabled technical consulting solutions for the environment, water, and energy transition markets...

MONACO, July 03, 2025 (GLOBE NEWSWIRE) -- Forty-two teams, twenty nations, 29 universities and more than one thousand students involved. These are the numbers of the 12th edition of the Monaco Energy Boat Challenge (1-5 July), the event dedicated to the future of yachting organised by Yacht Club de Monaco, with the support of the Prince Albert II of Monaco Foundation, UBS, BMW and SBM Offshore. The goal of the Challenge, which bridges the gap between academic research and the boating industry, is to rethink maritime mobility under real conditions.

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received Institutional Review Board (IRB) approval from Tel Aviv Sourasky Medical Center (TASMC) in Tel Aviv, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable patient enrollment at TASMC, a leading clinical site in Israel, prior to commencing this first-in-human trial at the site.

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and...

Hyundai IONIQ 5 XRT assembled at Hyundai Motor Group Manufacturing America (HMGMA) in GeorgiaNew, aggressive IONIQ 5 XRT adds rugged capability to America's Most Awarded EV...

FREMONT, Calif., July 3, 2025 /PRNewswire/ -- Weee! (www.sayweee.com), the leading online grocery platform specializing in authentic ethnic grocery delivery to the underserved communities...

ST. LOUIS, July 3, 2025 /PRNewswire/ -- Verde Resources Inc. (OTCQB: VRDR), an emerging leader in sustainable infrastructure solutions, proudly announces the appointment of Raymond...